Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL)

81 filings reported holding CADL - Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share as of Q4 2024.
Candel Therapeutics, Inc. - Common stock, par value $0.0001 per share (CADL) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17.9M shares of 49.6M outstanding shares and own 36.13% of the company stock.
Largest 10 shareholders include FMR LLC (3.92M shares), BAKER BROS. ADVISORS LP (2.98M shares), ACORN CAPITAL ADVISORS, LLC (1.94M shares), BRAIDWELL LP (1.6M shares), VANGUARD GROUP INC (1.34M shares), BlackRock, Inc. (1.18M shares), Portolan Capital Management, LLC (754K shares), Halter Ferguson Financial Inc. (681K shares), STATE STREET CORP (561K shares), and GEODE CAPITAL MANAGEMENT, LLC (455K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.